PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
237.14%
Net income growth above 1.5x CRK's 57.69%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
41.11%
Some D&A expansion while CRK is negative at -64.50%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
354.84%
Well above CRK's 62.64% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-136.96%
Both cut yoy SBC, with CRK at -3.86%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-62.71%
Negative yoy working capital usage while CRK is 752.09%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-132.76%
Both yoy AR lines negative, with CRK at -7.72%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.71%
Negative yoy usage while CRK is 1393.53%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
51.02%
Well above CRK's 52.93%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
71.27%
Operating cash flow growth above 1.5x CRK's 31.58%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-1.90%
Negative yoy CapEx while CRK is 12.73%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-120.27%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-155.56%
Both yoy lines negative, with CRK at -68.32%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-30.76%
We reduce yoy invests while CRK stands at 8.69%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-2505.00%
Both yoy lines negative, with CRK at -35.00%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
-59.25%
We cut yoy buybacks while CRK is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.